Cancers associated with extraovarian endometriosis at less common/rare sites: A nationwide survey in Japan. Issue 6 (25th March 2020)

• Record Type: Journal Article
• Authors: Mandai, Masaki; Osuga, Yutaka; Hirata, Tetsuya; Enomoto, Takayuki; Nakai, Hidekatsu; Honda, Ritsuo; Taniguchi, Fuminori; Katabuchi, Hidetaka
• Is Part Of: Journal of obstetrics and gynaecology research. Volume 46:Issue 6(2020)
• Page Start: 917
• Page End: 923
• Publication Date: 2020-03-25
• Subjects: histology -- incidence -- less common/rare site endometriosis -- malignant transformation -- nationwide survey; Gynecology -- Periodicals; Obstetrics -- Periodicals; 618.1005
• DOI: 10.1111/jog.14244
• Languages: English
• ISSNs: 1341-8076

Abstract

Abstract: Aim: Endometriosis mostly affects the ovary but can also be present outside of the ovary including the pelvic peritoneum, intestine, urinary tract and lung. In case of ovarian endometriotic cyst, an increased risk of ovarian cancer, especially of clear cell and endometrioid histology, has been reported. However, because of the rarity, cancer occurrence from endometriosis at less common sites/rare sites is poorly understood. Methods: We conducted a nationwide survey on the less common/rare site endometriosis in 3539 authorized facilities in Japan. We requested to complete a case report form for each case, including information on the history of endometriosis, treatment for endometriosis, type of surgery, involved site(s) of cancer and endometriosis, histology of cancer, chemotherapy and outcome. Results: Out of 1397 confirmed cases of less common/rare site endometriosis, 11 cases of rare site endometriosis‐associated cancer (RSEAC) were reported: seven of them were associated with intestinal endometriosis, three were associated with urinary tract endometriosis and one was associated with umbilical endometriosis. Interestingly, the histology was endometrioid in seven (64%) cases, and serous, seromucinous borderline, clear cell and mucinous in one case each (10%), differing from the case of ovarian endometriosis‐associated cancer, in which clear cell carcinoma are more common. Conclusion: Our nationwide survey on RSEAC has revealed that: (i) the incidence of malignant transformation may be lower than ovarian endometriosis, (ii) malignant transformation from endometriosis outside the abdominal cavity may be extremely rare and (iii) the histology of RSEAC is predominantly endometrioid type, suggesting an association of a hormonal effect.